CalmWave Names Healthcare and Technology Leader Andrew Thompson to Board of Advisors

Advisory Board of World-Class Subject Matter Expert Clinicians and Renowned IT and Operations Leaders Support Company in Eliminating All Non-Actionable Alarms

SEATTLE--(BUSINESS WIRE)--CalmWave, the leader in eliminating non-actionable clinical alarms through data science and Transparent AI, today announced the appointment of healthcare and technology entrepreneur and executive Andrew Thompson to the company's Board of Advisors. Thompson joins the advisory board of world-class subject matter expert clinicians and renowned IT and Operations leaders, which includes:

• Howard Wilson, Chief Financial Officer, PagerDuty
• Dr. Richard Schaefer, Chief Health Informatics Officer, US Department of Veterans Affairs
• Dr. Heather Giannini, ICU Physician
• Dr. Jack Storey, ED Physician
• Dr. Nicolas Mark, ICU Physician

“Andrew has spent his career at the nexus of healthcare and technology and has a deep appreciation for how to best address pressing problems facing our clinicians today, including alarm fatigue,” said Ophir Ronen, co-founder and CEO, CalmWave. “His expertise in hospital-focused healthcare aligns with our mission to revolutionize critical care environments. With Andrew on board, we are well positioned to accelerate our efforts in combating alarm fatigue through transparent AI, ultimately enhancing patient outcomes and staff retention.”

Thompson is a Silicon Valley-based executive, entrepreneur, and investor with a 30-year track record of successful technology-based innovation. From 2003 to 2020, he was Co-Founder, Chief Executive, and Board Member of Proteus Digital Health, leading the company to unicorn status and a valuation of over $1.5B. The company’s digital medicine solutions dramatically improved clinical outcomes delivered by oral drugs. From 1994 to 1999, he was Co-Founder, Chief Executive, and Board Member of FemRx, a pioneer of innovative solutions for women’s health, completing a NASDAQ IPO and subsequent sale to J&J. From 1991 to 1993, he was Co-Founder and Chief Financial Officer of CardioRhythm, a leader in minimally invasive arrhythmia surgery, acquired by Medtronic. From 1992 to 1995, he was Chairman of the Board at Kistler Morse, leading a turn-around and sale of the company to Danaher. Thompson is a named inventor on over 50 patents. He received master’s degrees in Engineering from Cambridge and Education and Business from Stanford.

“The widespread issue of alarm fatigue in ICUs poses a significant obstacle, undermining patient care and exacerbating the strain on nursing staff, who are grappling with escalating levels of burnout. Addressing this challenge is paramount,” said Thompson. “I am thrilled to join the team at CalmWave to improve the clinical working environment and optimize patient outcomes through the strategic integration of objective data and AI.”

CalmWave is at the forefront of deploying state-of-the art digital technology into healthcare operations. CalmWave ingests high-frequency hospital data in real time and provides clinicians with a holistic view of the information with which to make the most informed decisions regarding alarm management and patient care. By leveraging Transparent AI to build knowledge from the vast amounts of data generated in healthcare settings, CalmWave enhances patient care, reduces the burden on staff and improves hospital operating performance.

About CalmWave

CalmWave's mission is to improve the lives of patients and providers, starting with eliminating non-actionable alarms for a more stable and quiet ICU. Alarm fatigue, endemic in the modern healthcare system, causes great stress for providers, patients, and their families, detrimentally impacting patient outcomes and staff attrition. The CalmWave platform remediates alarm fatigue, improves staff retention, and transforms Operations Health through data science and Transparent AI. CalmWave was recognized with the prestigious “Health Innovation of the Year” at the 2024 GeekWire Awards, following its 2023 win, “UX Design of the Year”. CalmWave is the fastest company to go from inception to funding at the AI2 Incubator, a startup incubator at the Allen Institute for AI. Headquartered in Seattle, CalmWave investors include Bonfire Ventures, Tau Ventures, AI2 Incubator, SeaChange Ventures, Hike Ventures, and the co-founders of PagerDuty. Visit CalmWave.ai for more information. Follow us on LinkedIn and X.